Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $548.13 ($5.2M) on 2026-10-12, disclosed to the SEC on 2026-10-13.
Scheduled sale ($5.2M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $548.13 | 428 | $235K | 4.5% |
| 2 | $549.01 | 1,329 | $730K | 13.9% |
| 3 | $550.03 | 2,565 | $1.4M | 27.0% |
| 4 | $551.10 | 2,628 | $1.4M | 27.7% |
| 5 | $551.92 | 1,857 | $1.0M | 19.6% |
| 6 | $552.93 | 558 |
| $309K |
| 5.9% |
| 7 | $554.46 | 135 | $75K | 1.4% |
| Total | $550.70 avg | 9,500 | $5.2M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-14 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-09 | $5.1M | — | Filing → |